 hyperlipidemia nephrotic syndrome Lipid abnormalities patients nephrotic syndrome significance lipid abnormalities mechanisms potential treatment cause debate Recent data areas controversy Studies lipoprotein abnormalities patients uncomplicated nephrotic syndrome many levels total low-density lipoprotein cholesterol levels high-density lipoprotein cholesterol lipid abnormalities significance population populations patients unremitting nephrotic syndrome high risk cardiovascular disease elevated cholesterol levels nephrotic syndrome enhanced hepatic synthesis contributions decreased clearance enzyme activities signal enhanced hepatic lipogenesis changes plasma albumin concentration plasma oncotic pressure local effect viscosity hepatic sinusoidal level loss urinary proteins liporegulatory substances number short-term studies nephrotic patients safety efficacy lipid-lowering drugs bile acid-binding resins probucol HMGCoA hydroxymethylglutaryl reductase inhibitors